Table 1 Characteristics of patients and normal subjects.
From: Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome
Pt.# | T # | Age | Sex | Clinical | LN Mets | T Vol. (ml) | Menin Defect [6] |
|---|---|---|---|---|---|---|---|
1 | 1 | 19 | F | Insulinoma | 0/1 | 8.28 | Large Deletion, exon 1 & 2 |
2 | 2 | 42 | M | Neuroendocrine Tumor | 0/14 | 18.75 | Nonesense Mutation, exon 7 |
6 | 6 | 60 | M | VIP-oma | 1/16 | 288 | 8 bp Deletion, exon 5 |
7 | 7 | 51 | M | Neuroendocrine Tumor | 2/30 | 3.75 | 2 bp Deletion, exon 2 |
8 | 8–10 | 22 | M | Insulinoma | 2/8 | 6.9 | 2 bp Deletion, exon 2 |
11 | 11 | 57 | M | Gastrinoma | 1/1 | 0.5 | 4 bp Deletion, exon 3 |
N1 | N1 | 52 | M | Normal | NA | NA | NA |
N2 | N2 | 56 | F | Normal | NA | NA | NA |
N3 | N3 | 52 | F | Normal | NA | NA | NA |
N4 | N4 | 42 | M | Normal | NA | NA | NA |